Jim Simons
UBX

Jim Simons’s Unity Biotechnology UBX Stock Holding History

Jim Simons’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-98,311
Closed -$37.8K – 3942
2025
Q2 		$37.8K Buy
98,311
+4,100
+4% +$3.51K ﹤0.01% 3423
2025
Q1 		$98K Buy
94,211
+17,300
+22% +$31.2K ﹤0.01% 3201
2024
Q4 		$75.1K Sell
76,911
-16,759
-18% -$20.8K ﹤0.01% 3326
2024
Q3 		$138K Buy
93,670
+29,088
+45% +$42.7K ﹤0.01% 3201
2024
Q2 		$87.2K Sell
64,582
-42,359
-40% -$64.3K ﹤0.01% 3208
2024
Q1 		$175K Buy
106,941
+68,770
+180% +$119K ﹤0.01% 3258
2023
Q4 		$74K Sell
38,171
-200
-0.5% -$372 ﹤0.01% 3378
2023
Q3 		$92K Sell
38,371
-4,100
-10% -$10.9K ﹤0.01% 3268
2023
Q2 		$108K Sell
42,471
-35,000
-45% -$92.4K ﹤0.01% 3453
2023
Q1 		$126K Sell
77,471
-13,700
-15% -$54.9K ﹤0.01% 3420
2022
Q4 		$250K Sell
91,171
-67,066
-42% -$195K ﹤0.01% 3319
2022
Q3 		$625K Buy
158,237
+62,465
+65% +$394K ﹤0.01% 2789
2022
Q2 		$540K Buy
95,772
+5,100
+6% +$42.5K ﹤0.01% 3122
2022
Q1 		$1.02M Sell
90,672
-17,098
-16% -$192K ﹤0.01% 2719
2021
Q4 		$1.57M Buy
107,770
+43,700
+68% +$955K ﹤0.01% 2341
2021
Q3 		$1.92M Buy
64,070
+12,810
+25% +$452K ﹤0.01% 2121
2021
Q2 		$2.38M Buy
+51,260
New +$2.47M ﹤0.01% 2145
2020
Q3 		– Sell
-28,090
Closed -$2.44M – 3697
2020
Q2 		$2.44M Buy
28,090
+13,650
+95% +$1.01M ﹤0.01% 2083
2020
Q1 		$838K Buy
14,440
+11,440
+381% +$721K ﹤0.01% 2509
2019
Q4 		$216K Buy
+3,000
New +$212K ﹤0.01% 3178

Other funds holding UBX

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return

Jim Simons's UBX Position: Q3 2025 in Review

Jim Simons sold out of Unity Biotechnology (UBX) in Q3 2025, closing a stake of 98,311 shares — an estimated $37.8K sold.

Jim Simons first reported a position in UBX in Q4 2019 and held it in 20 quarters. The position peaked at $2.44M in Q2 2020. 6 funds tracked by Wall St. Rank hold UBX as of Q3 2025.

  • Jim Simons reported no remaining Unity Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Jim Simons sold 98,311 Unity Biotechnology shares in Q3 2025, an estimated $37.8K.
  • Jim Simons first reported a position in Unity Biotechnology in Q4 2019 and held it in 20 quarters.
  • Jim Simons's Unity Biotechnology position peaked at $2.44M in Q2 2020.
  • 6 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2025.

Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.